Enclomiphene certificate of analysis, explained

Last updated 2026-07-27

What is a certificate of analysis, actually?

A certificate of analysis is a document a lab issues after testing a specific batch of a substance. It reports what the batch actually contains: identity (is this really enclomiphene citrate?), potency (how many mg per unit, or what percentage purity), and contaminants (heavy metals, residual solvents, microbial load, endotoxin for injectables). It is not a promise about safety, and it's not a stand-in for FDA approval. It's a snapshot, tied to one batch, one test date, one lab. A COA from March tells you nothing about the vial you bought in September unless the batch numbers match. For FDA-approved drugs, the manufacturer's own quality system (validated under 21 CFR Part 211) does this work behind the scenes, and the public rarely sees a COA. Compounded drugs work differently. There's no FDA approval process for the finished product, so the COA (or the absence of one) is often the only paper trail a buyer gets ^[1].

Why does enclomiphene specifically need a COA (it's not FDA-approved)?

Enclomiphene citrate has never been approved by the FDA as a standalone drug. A company called Repros Therapeutics ran it through Phase 3 trials under the name Androxal for secondary hypogonadism, and the program did not reach approval. FDA's drug database, Drugs@FDA, has no approved application for enclomiphene as of this writing ^[2]. What's sold today is compounded enclomiphene, made by a licensed compounding pharmacy under Section 503A of the Federal Food, Drug, and Cosmetic Act, typically against an individual prescription. Section 503A compounding is exempt from the FDA's premarket approval requirements, but that exemption comes with a tradeoff: no FDA review of safety or efficacy for that specific formulation, and no FDA-mandated batch testing standard the way there is for approved drugs. That's the gap a COA is supposed to fill. It's the pharmacy (or a lab it hires) telling you: here's what's actually in this batch. Whether you can trust that document depends entirely on who wrote it and how it was tested, which is the next question.

Is enclomiphene the same as clomiphene? Why the COA distinction matters

No, and mixing these up is the single most common confusion buyers have. Clomiphene citrate (brand name Clomid, FDA-approved for female infertility) is actually a 50/50 mixture of two isomers: enclomiphene and zuclomiphene ^[3]. Enclomiphene is the trans-isomer, generally considered the more active component at the hypothalamus for raising LH and FSH. Zuclomiphene, the cis-isomer, has a much longer half-life and different estrogenic activity, and its contribution to clomiphene's effects and side effects is still debated in the literature ^[4]. When a compounding pharmacy sells 'enclomiphene,' the COA should confirm it's the isolated enclomiphene citrate, not full clomiphene, and not a mixture with meaningful zuclomiphene contamination. This is an identity test, more than a potency test. A cheap or sloppy COA might just say 'clomiphene-related compound, 98% pure' without actually distinguishing the isomers, which tells you almost nothing about what you're injecting or dosing. If you're comparing enclomiphene to clomiphene as a TRT-adjacent option, the isomer question is the whole ballgame. It's also why potency alone on a COA isn't enough. You want identity confirmation specific to enclomiphene, ideally by a method like HPLC or LC-MS that can separate the isomers, more than a generic assay.

What does enclomiphene actually do, and why does the fertility claim matter for sourcing?

Enclomiphene works as a selective estrogen receptor modulator (SERM) at the hypothalamus. It blocks estrogen's negative feedback signal there, which prompts the hypothalamus to increase GnRH pulses, which in turn raises LH and FSH from the pituitary. More LH drives the testes to produce more of their own testosterone; more FSH supports spermatogenesis. That's the mechanistic reason enclomiphene tends to preserve testicular size and sperm production, in contrast to exogenous testosterone (TRT), which suppresses LH/FSH via the same feedback loop and commonly shrinks the testes and drops sperm counts. Small clinical studies support the general direction of this effect. A randomized trial published in the Journal of Sexual Medicine found enclomiphene raised testosterone while maintaining or increasing LH and FSH, in men with secondary hypogonadism who wanted to preserve fertility, compared to testosterone gel which suppressed gonadotropins ^[5]. That's a real and clinically useful contrast. But it is not the same as a guarantee of fertility outcomes like pregnancy rates or sperm count normalization, and the enclomiphene trials were mostly small and short. Nobody should sell you enclomiphene with a promise that it will make you (or keep you) fertile; the honest claim is that it preserves the hormonal signaling that testosterone production and spermatogenesis depend on, more than exogenous TRT does. Why does this connect to the COA question? Because if the whole reason you're choosing enclomiphene over TRT is fertility preservation, then dosing accuracy actually matters clinically, more than as a purity abstraction. An underdosed vial might not suppress you, but it also might not raise LH/FSH enough to do anything. An overdosed one could push estrogen-blocking effects further than intended. The COA's potency number is the only way to know what dose you're actually taking, which then determines what you inject; see Enclomiphene Direct dosage and the dosage calculator for how that translates into volume.

What should a legitimate enclomiphene COA actually contain?

A COA worth trusting should include, at minimum: - Batch or lot number, matching the number printed on your vial

• Test date, ideally close to the manufacture date, not years old
• Identity confirmation (HPLC or LC-MS/MS), specifically for enclomiphene citrate, not generic 'clomiphene-class compound'
• Potency/assay result, given as mg per mL or percentage of labeled claim, with an acceptance range (commonly 90-110% of label claim is a standard pharmacopeial range for many compounded preparations, though the exact range should be stated, not assumed)
• Sterility and endotoxin testing, if the product is injectable, since USP <797> and <71> govern sterile compounding standards ^[2]
• Heavy metals and residual solvent screening
• Name and accreditation of the testing lab (ISO 17025 accreditation is the relevant standard for testing labs)
• Signature or reference number tying it to a specific pharmacy's compounding record A COA missing the batch number, or one that's clearly a generic template reused across products, is a red flag. So is a COA from a lab you can't find or verify exists. | COA element | Why it matters | Red flag if missing |

Third-party lab vs. in-house testing: does it matter?

Yes, meaningfully. In-house testing means the compounding pharmacy tests its own product and issues its own COA. Third-party testing means an independent lab, with no financial stake in the pharmacy's sales, runs the analysis. In-house testing isn't automatically dishonest. Many pharmacies have legitimate internal quality control required under USP compounding chapters. But it does create an obvious incentive problem: the entity grading its own homework has less pressure to report a failed batch. Third-party testing removes that specific conflict, though it costs more, and a smaller compounding pharmacy may not do it on every batch. What you actually want to know, as a buyer, is: who ran this test, and can I verify that lab exists independently of the pharmacy? A quick search for the lab's name plus 'ISO 17025' or checking a state pharmacy board's compounding oversight page is a reasonable five-minute check before you trust a number on a PDF.

What oversight actually exists for compounding pharmacies (and what doesn't)?

Compounding pharmacies operating under Section 503A of the FD&C Act are regulated primarily by state boards of pharmacy, not the FDA, for their day-to-day compounding practice. FDA's role under 503A is narrower: it can act on adulteration, misbranding, or health fraud, but it does not pre-approve compounded formulations or routinely batch-test them the way it does approved drugs . Separately, some larger compounders register as 503B 'outsourcing facilities,' which do fall under more direct FDA oversight, including required adherence to current Good Manufacturing Practice (cGMP) and FDA inspection authority . If a pharmacy is 503B-registered, that's a meaningfully different (higher) regulatory bar than a standard 503A pharmacy, and it's worth asking which one is fulfilling your prescription. USP General Chapters <795> (non-sterile compounding) and <797> (sterile compounding) set the compounding practice standards that most state boards adopt or reference; USP <797> specifically addresses environmental monitoring, personnel testing, and beyond-use dating for sterile preparations like injectable enclomiphene ^[2]. None of these chapters require a public-facing COA for every batch sold to a patient. That's a pharmacy-level choice, which is exactly why it's worth asking about before you buy, not after.

How do you actually verify a COA is real and matches your vial?

Three checks, in order of how fast they are: 1. Match the batch/lot number on the COA to the number printed on your vial label. If they don't match, the document is worthless to you regardless of what it says. 2. Look up the testing lab independently. A real lab has a findable business registration, an address, and ideally ISO 17025 accreditation. If you can't find the lab existing anywhere except on that one PDF, treat the COA as unverified. 3. Ask the seller directly whether the COA is third-party or in-house, and whether it's a fresh document for the batch you're buying or a stock document used across shipments. A pharmacy with nothing to hide answers this without friction. A COA you can't verify is functionally the same as no COA. It might still be accurate, but you have no way to know that, and 'might be accurate' isn't a great basis for injecting something into your body long-term.

What should you do if a seller can't or won't provide a COA?

Walk away, or at minimum treat it as a serious downgrade in trust. There's no good reason a legitimate compounding pharmacy can't produce a batch-specific COA on request; it's standard practice for any pharmacy running proper quality control, and reputable telehealth platforms sourcing from licensed pharmacies typically make this available or will get it for you. The honest reality: compounded enclomiphene sits in a regulatory space with less centralized oversight than FDA-approved drugs, which puts more of the verification burden on the pharmacy's own practices and, indirectly, on you as the buyer asking the right questions. A provider-reviewed path, where a licensed prescriber evaluates your labs and symptoms before a prescription goes to a compounding pharmacy, at least adds a professional accountability layer beyond an anonymous online storefront. Enclomiphene Direct works this way: prescriptions go through provider review and are filled by a named pharmacy partner, which is a meaningfully different accountability structure than buying an unlabeled vial off a research-chemical site with no prescriber involved at all. If you're this far into vetting a source, you've probably also got dosing logistics ahead of you: how to draw up the correct volume, where to inject, and how long a reasonable cycle runs. Those are covered separately at how to reconstitute Enclomiphene Direct, Enclomiphene Direct how to inject, injection sites, and cycle length.

How does enclomiphene sourcing compare to buying FDA-approved TRT?

With FDA-approved testosterone products (gels, injections like testosterone cypionate, pellets), the manufacturer's entire production line is inspected and validated under 21 CFR Part 211, and the FDA has approved the specific formulation through an NDA or ANDA process documented in Drugs@FDA ^[2] . You don't get a COA as a patient because you don't need one: the approval process already did that verification work at scale, across every batch, as a legal condition of sale. With compounded enclomiphene, that centralized verification doesn't exist. Every pharmacy is its own quality system, subject to state board oversight and USP chapters, but without a single national approval standard for this specific drug. That's not automatically dangerous. Plenty of legitimate compounding pharmacies produce consistent, well-tested products, and compounding fills a real need for patients whose situation isn't served by an approved product. But it does mean the burden of verification shifts, partly, to you. A COA is the tool for that shift. Treat it as required homework, not an optional nice-to-have.

Frequently asked questions

What is a certificate of analysis for enclomiphene?

It's a lab report on one specific batch of compounded enclomiphene, listing identity confirmation, potency (mg/mL or % of label claim), and contaminant screening (heavy metals, residual solvents, sterility/endotoxin for injectables). It should show a batch number matching your vial and the name of the testing lab. It is not proof of FDA approval, since enclomiphene has none.

Is enclomiphene FDA-approved?

No. Enclomiphene was studied under the name Androxal by Repros Therapeutics in Phase 3 trials for secondary hypogonadism, but the program never reached FDA approval. There is no approved enclomiphene product listed in FDA's Drugs@FDA database. What's sold today is compounded under Section 503A of the FD&C Act, typically against an individual prescription.

Is enclomiphene the same as clomiphene?

No. Clomiphene citrate (Clomid) is a 50/50 mixture of two isomers, enclomiphene (trans) and zuclomiphene (cis). Enclomiphene alone is generally considered the more active isomer for raising LH and FSH, while zuclomiphene has a longer half-life and different estrogenic activity. A COA should confirm isolated enclomiphene identity, more than generic 'clomiphene-class' purity.

Does enclomiphene preserve fertility better than TRT?

It tends to, mechanistically and in small trials, because it raises LH/FSH rather than suppressing them the way exogenous testosterone does. A Journal of Sexual Medicine trial found enclomiphene maintained or increased LH/FSH and raised testosterone, versus testosterone gel which suppressed gonadotropins. That's a real contrast, but it's not a guaranteed fertility outcome; studies are small and short-term.

Why does compounded enclomiphene need a COA if FDA-approved drugs don't show me one?

Approved drugs are validated under 21 CFR Part 211 as a legal precondition of sale, with FDA inspection of the whole manufacturing process. Compounded drugs under Section 503A skip that centralized federal approval; oversight sits mainly with state pharmacy boards. A COA is the pharmacy's own substitute evidence that a given batch is what it claims to be.

What's the difference between a 503A and 503B compounding pharmacy?

503A pharmacies compound against individual prescriptions and are regulated mainly by state boards, without FDA cGMP requirements. 503B 'outsourcing facilities' register with the FDA, must follow current Good Manufacturing Practice, and are subject to FDA inspection. A 503B source generally carries a higher regulatory bar; it's reasonable to ask which type is filling your prescription.

How do I know if a COA is legitimate or fake?

Check three things: the batch/lot number on the COA matches your vial label exactly, the testing lab is independently findable (ideally ISO 17025 accredited) rather than existing only on that PDF, and the seller confirms whether it's third-party or in-house testing. If any of these fail, treat the document as unverified regardless of how official it looks.

Should I trust in-house testing from the compounding pharmacy itself?

It's not automatically dishonest, and many pharmacies run legitimate internal QC required under USP compounding chapters. But it has an obvious incentive problem, since the pharmacy is grading its own product. Third-party testing from an independent lab removes that conflict and is the stronger standard when it's available.

What testing should an injectable enclomiphene COA include that an oral version wouldn't need?

Sterility testing and bacterial endotoxin testing, governed by USP General Chapter <797> for sterile compounding. Oral formulations don't carry the same infection risk from contamination, so those specific tests matter much more for an injectable product than for a capsule or oral solution.

What does '90-110% of label claim' mean on a potency test?

It's a common acceptance range used in pharmacopeial testing, meaning the actual measured amount of active drug should fall within 90% to 110% of what the label states. A COA should state its own acceptance range explicitly rather than you assuming a standard number, since ranges can vary by preparation type and testing method.

Can I ask my provider or pharmacy directly for a COA before starting enclomiphene?

Yes, and you should. A legitimate compounding pharmacy or a provider-reviewed telehealth service working with a named pharmacy partner should be able to produce a batch-specific COA on request without friction. If a seller refuses or stalls, treat that refusal itself as meaningful information.

Does a COA tell me anything about dosing or how much to inject?

Indirectly, yes. The potency result (mg/mL) on the COA is exactly the number you need to calculate an accurate injection volume for your prescribed dose. Without a verified potency figure, any dosing calculation is built on an assumption rather than a measured fact.

Sources

1. eCFR, Title 21 Part 211 (cGMP for Finished Pharmaceuticals): FDA-approved drugs are validated under 21 CFR Part 211 manufacturing quality standards
2. FDA, Drugs@FDA database: No approved enclomiphene product exists in FDA's drug approval database
3. FDA, Compounding and FDA: Questions and Answers: Section 503A compounding pharmacies are exempt from certain FDA premarket approval requirements
4. Kim et al., Journal of Sexual Medicine: Enclomiphene raised testosterone while maintaining/increasing LH and FSH compared to testosterone gel
5. USP, General Chapter <797> Pharmaceutical Compounding - Sterile Preparations: USP <797> governs sterility, endotoxin testing, and environmental standards for sterile compounded drugs